Allocations
Funds advised by Bain Capital Private Equity and Cinven Partners intend to launch a voluntary public takeover offer for all outstanding shares of STADA Arzneimittel.
STADA is an independent pharmaceutical company listed on the Frankfurt Stock Exchange.
The company offers a portfolio of high-quality, low-cost generic products including selected biosimilars. STADA has also built an attractive portfolio of well-established branded products, including the cold medicine Grippostad and the Ladival range of sun protection products.
Bain and Cinven offer the shareholders of STADA a cash consideration of EUR 65.28 per share plus the 2016 dividend in the amount of
The Klöckner Pentaplast Group (KP), a specialist in rigid plastic film and packaging solutions, has signed a binding agreement to acquire LINPAC Senior Holdings and its direct and indirect subsidiaries (LINPAC), a film producer and converter for food packaging in Europe.
Financial terms of the transaction have not been disclosed.
The transaction will create a global leader in the rigid and flexible film market, with combined annual revenues exceeding USD2 billion.
Wayne M Hewett, CEO of KP, says: “This is a highly complementary acquisition that will help KP expand our technological capabilities and presence into the food industry and
Benhamou Global Ventures (BGV), an early-stage venture capital firm, has completed two more exits from BGV II, which first invested in 2014.
Zentri, a BGV II seed investment, was acquired by Silicon Labs.
Grid Dynamics, another early BGV II investment was acquired by Teamsun through its Hong Kong subsidiary Automated Systems.
"These two exits showcase our fund's investment strategy when investing in early stage enterprise IT," says Anik Bose, general partner at Benhamou Global Ventures. "BGV's cross border innovation combined with the partnership's deep company building experience and ecosystem relationships continue to deliver favourable outcomes for each portfolio
Accel-KKR, a technology-focused private equity firm, has sold its portfolio company Abila to Community Brands.
Accel-KKR acquired Abila in 2013 when the business, which provides software and services to associations, non-profit organisations and governmental entities, was spun-off from UK-based The Sage Group.
Following its initial investment in 2013, Accel-KKR rebranded the company, augmented the management team, and invested to build the infrastructure to position the company for significant organic growth and strategic consolidation.
During the past four years, Abila grew its revenues threefold, integrated three acquisitions to expand its product offerings in the non-profit and association sector, and
Foresight has invested GBP2.15 million from Foresight VCT into Fresh Relevance Limited (FRL), a marketing technology platform for eCommerce businesses.
Fresh Relevance is a SaaS email marketing and web personalisation platform providing online retailers with personalised customer experiences and real-time marketing tools across desktop and mobile.
Key features of the platform include triggered emails, web personalisation and real-time behavioural marketing, all of which aim to replicate the personalised experience familiar across market leading eCommerce businesses.
Based in Southampton, Fresh Relevance was founded by Mike Austin, Pete Austin and Eddy Swindell, ex-employees of former Foresight private equity portfolio company
HarbourVest Partners, a global private markets asset manager, has held the final closes of its first mezzanine-focused co-investment fund at USD375 million and its third real assets fund at USD366 million.
“Specialised programmes such as our mezzanine and real assets funds demonstrate our continued emphasis on offering solutions that help our clients invest in niche strategies and markets that are difficult to access,” says John Toomey, managing director, HarbourVest.
“HarbourVest’s growth in real assets and expansion into private credit further broadens the reach of our solutions and our ability to meet and anticipate client needs. We are particularly proud
JLT Specialty, the insurance broker and risk consultant, saw a 60 per cent increase in the number of insured deals during 2016 compared to 2015 globally.
This type of mergers and acquisitions (M&A) insurance, also known as warranty and indemnity (W&I) insurance – of which the real estate and private equity sector remain the key beneficiaries of – is designed to pay out if a buyer discovers the business bought is not what the seller advised it would be.
In its annual M&A Insurance Index report, JLT found that the average limit of insurance (as a percentage of the
Fresenius Medical Care, a provider of dialysis products and services, has acquired a 70 per cent equity interest in Kunming Wuhua Health Hospital (Wuhua Hospital) in China, specialised in chronic-disease management and haemodialysis (HD).
The acquisition was officially completed on 31 March 2017. This marks Fresenius Medical Care's first joint venture (JV) hospital in China, with the aim of providing high-standard renal-care services and chronic-disease management to local community.
There are 900,000 people living in Wuhua district and 9.8 million residents in Kunming City. Wuhua Hospital is a private Grade II hospital located in Wuhua district in the center of
LMS Capital has sold its majority stake in UK IT services business 365IT to CORETX Holdings, a mid-market network, cloud and IT managed services provider.
Under the terms of the acquisition the enterprise value of 365IT was agreed at GBP5.4 million, which after adjusting for net debt of GBP800,000 results in an equity value of GBP4.6 million, to be settled through a combination of cash and shares.
LMS' share of the equity value is GBP4.1 million. LMS has received gross cash proceeds of GBP1.1 million plus 9,826,400 shares in CORETX having a value of GBP3 million based on a
Cairngorm Capital Partners has closed its second fund – Cairngorm Capital II – at its GBP107.5 million hard cap.
The fund, which was oversubscribed, is now fully operational.
Cairngorm Capital has been backed by a consortium of long-term, international institutional investors, consisting of several prestigious European funds of funds and US university endowments.
Each of the institutional investors in its first fund increased their commitment to Fund II. In line with Cairngorm Capital’s investment philosophy, a significant investment was made by the firm’s principals.
The launch of the second fund continues Cairngorm Capital’s expansion of its business.
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
